MPM BioImpact’s Inhibrx INBX Stock Holding History
Bought
Maintained
Sold
Other funds holding INBX
MPM BioImpact's INBX Position: Q2 2023 in Review
MPM BioImpact sold out of Inhibrx (INBX) in Q2 2023, closing a stake of 1,192,281 shares — an estimated $22.5M sold.
MPM BioImpact first reported a position in INBX in Q2 2022 and held it in 4 quarters. The position peaked at $31.7M in Q4 2022. 106 funds tracked by Wall St. Rank hold INBX as of Q2 2023.
- MPM BioImpact reported no remaining Inhibrx position as of Q2 2023 after selling out during the quarter.
- MPM BioImpact sold 1,192,281 Inhibrx shares in Q2 2023, an estimated $22.5M.
- MPM BioImpact first reported a position in Inhibrx in Q2 2022 and held it in 4 quarters.
- MPM BioImpact's Inhibrx position peaked at $31.7M in Q4 2022.
- 106 funds tracked by Wall St. Rank held Inhibrx as of Q2 2023.
Based on MPM BioImpact's 13F filing for Q2 2023, filed 14 Aug 2023.